Click to Translate to English Click to Translate to French  Click to Translate to Spanish  Click to Translate to German  Click to Translate to Italian  Click to Translate to Japanese  Click to Translate to Chinese Simplified  Click to Translate to Korean  Click to Translate to Arabic  Click to Translate to Russian  Click to Translate to Portuguese


Forum Home Forum Home > General Discussion > Latest News
  New Posts New Posts RSS Feed - Flu Drugs Losing Effectiveness
  FAQ FAQ  Forum Search   Events   Register Register  Login Login

Online Discussion: Tracking new emerging diseases and the next pandemic

Flu Drugs Losing Effectiveness

 Post Reply Post Reply
Author
Message
Technophobe View Drop Down
Senior Moderator
Senior Moderator
Avatar

Joined: January 16 2014
Location: Scotland
Status: Offline
Points: 55215
Post Options Post Options   Thanks (0) Thanks(0)   Quote Technophobe Quote  Post ReplyReply Direct Link To This Post Topic: Flu Drugs Losing Effectiveness
    Posted: January 27 2019 at 2:04pm
[Technophobe: This should have been Rishat's post, but it went west with the rest of his rubbish, when I spam-cleaned his latest alias.]

Flu viruses resistant to new drug Xofluza uncovered in Japan

Mutated influenza viruses resistant to baloxavir marboxil, a new flu drug sold as Xofluza, were detected in patients last month, the National Institute of Infectious Diseases has said.

This was the first confirmation by a national research institute of such mutations in flu viruses since the drug was put into practical use last March, the health ministry said.

According to the NIID, Xofluza-resistant viruses were found in two of four primary school students in Yokohama in generic screenings in December conducted after they developed flu symptoms earlier the same month.

The mutated viruses were 76 to 120 times more resistant to the new anti-flu drug developed by Shionogi & Co. than unmutated ones detected in the other two children.

In clinical trials of baloxavir marboxil, resistant viruses were detected in 23.4 percent of participating patients younger than 12 years old.

The NIID said that it will continue to keep an eye on mutated flu viruses and provide related information swiftly.

Sales of Xofluza have been increasing because only one dose of the drug is enough for treatment, according to the drug maker and other sources.

The health ministry said last week that the number of influenza patients per medical institution in Japan in the week through Jan. 20 had hit the second-highest level since the survey started in 1999.

The average number of flu patients at some 5,000 medical institutions across the country that are regularly monitored grew by 15.37 from the previous week to 53.91, following the record high of 54.33, marked in the previous year, the ministry announced Friday.

The total number of flu patients during the week is estimated at some 2.13 million, up by some 495,000 from the previous week.

Source: https://www.japantimes.co.jp/news/2019/01/27/national/science-health/flu-viruses-resistant-new-drug-xofluza-uncovered-japan/#.XE4o283gqM8
Absence of proof is not proof of absence.
Back to Top
carbon20 View Drop Down
Admin Group
Admin Group


Joined: April 08 2006
Location: West Australia
Status: Offline
Points: 27131
Post Options Post Options   Thanks (0) Thanks(0)   Quote carbon20 Quote  Post ReplyReply Direct Link To This Post Posted: January 27 2019 at 3:04pm
it didnt take long for it to Mutate...........
12 Monkeys...............
1995 ‧ Science fiction film/Thriller ‧ 2h 11m a must for AFT
Back to Top
 Post Reply Post Reply
  Share Topic   

Forum Jump Forum Permissions View Drop Down